ARCHIVES

GAO Investigation Of Cancer Control Focuses On Five Contracts, Finds Alleged Deficiencies

This article is from The Cancer Letter archive.

Vol. 06 No. 29 | July 18, 1980

Download PDF Visit The Full Archive

Related Articles

Phase II Study Of Pfizer Drug Meets Primary Endpoint

April 24, 2009

Crawford Testimony in 2002 Promised Job to Pazdur.

February 18, 2005

FDA Committee Oks AMSA for Group C List, Tables THC Request, Deadlocks On Estramustine NDA

July 3, 1981

Clinical Trials Approved by NCI CTEP Last Month

August 26, 2011

Managed Care Plans Seek Cost Efficacy, Not Research, Center Directors Warned

March 17, 1995

NCI Supports New Cervical Cancer Screening Guideline

January 31, 2003